TEM.NASDAQTempus Ai, INC

Form 4: Tempus AI EVP Andrew Polovin Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4


Andrew Polovin, EVP and General Counsel of Tempus AI, sold shares of Class A Common Stock on March 18, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On March 18, 2025, Andrew Polovin, the EVP and General Counsel of Tempus AI, sold shares of Class A Common Stock.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on September 6, 2024.
  • A total of 13,135 shares were sold in multiple transactions at varying prices.
  • The weighted average sale prices were $45.78, $46.38, and $47.37.
  • Following the reported transactions, Polovin beneficially owns 154,171 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider trading activity under a pre-arranged plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information.

Stakeholder Impact

  • The sale of shares by an executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
09/06/2024Date of adoption of Rule 10b5-1 trading plan
03/18/2025Date of transaction (sale of shares)
03/19/2025Date of signature on the SEC Form 4

Keywords

Tempus AI, Andrew Polovin, Class A Common Stock, Rule 10b5-1, SEC Form 4, Insider Trading, Share Sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.